#RepublicDay2022 Contributing to advanced healthcare infrastructure in India. First glimpse of the Cellular Therapy Facility Tata Medical Center. An academia-industry collaboration between Tata Medical Center, Intas pharmaceuticals and #Lentigen Miltenyi Biotec. Funded by DBT-BIRAC Department of Biotechnology

In the works from 2018. The facility awaits cGMP accreditation by CDSCO_INDIA_INFO Ever grateful to Prof. Mammen Chandy's vision and the collaborative team we put up within Tata Medical Center and Intas pharma, facilitated through a competitive and generous DBT-BIRAC NBM grant.

The facility houses a point of care manufacturing system using Miltenyi Biotec Prodigy system and related infrastructure (including MACSQuant). Dr. Lakshmikanth Gandikota (Intas Pharma) and Pradyot Dash (Miltenyi Biotec) visit late last year.

📄 Relapsed Refractory #HodgkinLymphoma and Brentuximab Vedotin-Bendamustine Combination Therapy as a Bridge to Transplantation: RWE From a Middle-Income Setting 👨‍⚕️👩‍⚕️ Vivek Radhakrishnan Read here 👉 fro.ntiers.in/mwMT Reena Nair Tata Medical Center #Lymphoma #LYMsm #HemOnc #ImmunOnc